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Abstract
The purpose of this study was to examine the relationships 
among uncertainty, perceived social support, posttraumatic stress 
symptoms and psychological growth in patients with hematologic 
cancers, and to identify factors influencing posttraumatic stress 
symptoms and psychological growth. 
A predictive correlational design was used. Data were 
collected by survey interview using questionnaires during 2014, 166 
participants diagnosed with hematologic cancer from a university 
hospital located in Seoul. Uncertainty was measured by Mishel’s 
Uncertainty in Illness Scale – Community Form, perceived social 
support was measured by Multidimensional Scale of Perceived Social 
Support, posttraumatic stress symptoms was measured by PTSD 
Checklist – Civilian Version and psychological growth was measured 
by Growth Through Uncertainty Scale. Data were analyzed using 
Windows SPSS 21.0 program.
Significant correlations were identified among all four 
variables. As a result of multiple regression analysis, uncertainty and 
perceived social support were discovered to account for 31.2% of the 
variance in posttraumatic stress symptoms. Perceived social support, 
bone marrow transplantation or relapse, psychological treatment, and 
economic status were discovered to account for 23.1% of the variance 
in psychological growth. The variable that most affected a 
posttraumatic stress symptom was uncertainty and the variable that 
most affected a psychological growth was perceived social support.
The results of the study demonstrate the importance of 
uncertainty and social support in explaining posttraumatic stress 
symptoms and psychological growth. Thus, uncertainty and social 
support needs to be integrated in developing psychosocial interventions 
to relieve psychological stress and to promote psychological growth in 
patients with hematologic cancers. 
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Student ID: 2012-20423
Table of Contents
CHAPTER I. INTRODUCTION ·····························································   1
1. Background ·····················································································   1
2. Purpose of the Study ····································································   4
3. Definitions of Terms ·····································································   4
CHAPTER II. LITERATURE REVIEW ················································   7
1. Uncertainty ······················································································   7
2. Perceived Social Support ·······························································   9
3. Posttraumatic Stress Symptoms ····················································  11
4. Psychological Growth ····································································  14
CHAPTER III. THEORETICAL FRAMEWORK ·································  16
CHAPTER IV. METHODS ·····································································  20
1. Study Design ··················································································  20
2. Setting and Sample ········································································  20
3. Data Collection Procedure ·····························································  22
4. Measures ··························································································  23
5. Data Analysis ·················································································  28
6. Ethical Consideration ·····································································  29
CHAPTER V. RESULTS ········································································  31
1. Characteristics of the Participants ················································  31
2. Standardized Scores of the variables ···········································  35
3. Correlations between variables ·····················································  47
4. Multiple Regression of PTSS ·······················································  48
5. Multiple Regression of Psychological Growth ···························  49
CHAPTER VI. DISCUSSION ·································································  50
CHAPTER VII. CONCLUSION ·····························································  56
REFERENCES ·························································································   58
APPENDICES ··························································································   68




Hematologic cancers are the 10th most common tumor group 
of adults in Korea with an estimate of 4,367 new cases of 
non-Hodgkin’s lymphoma and 1,719 cases of acute leukemia annually 
(National Cancer Information Center, 2011). These are the two most 
common hematologic cancers. Hematologic cancers are the cancers of 
the bone marrow which is leukemia, and the cancers of the immune 
system is called the lymphoma and myeloma. 
Effective treatment targeting hematologic cancers has marked 
effects on normal bone marrow and immune function. Consequently, 
treatment is more complex and debilitating than other cancer 
treatments, with increased risk of severe infection, and the need for 
bone marrow support with red blood cells and platelet transfusions. 
The most complex treatments are autologous and allogeneic bone 
marrow transplantation. Patients who receive bone marrow 
transplantation, and high dose chemotherapy treatment requires 
intensive isolation care for a long time period due to their extremely 
low immune system (Marrs, 2006; Ropka & Padilla, 2007; Shelton, 
2003). 
Intensive hematologic cancer therapy, including high-dose 
chemotherapy, total body irradiation and bone marrow transplantation 
has been proven to treat the disease and extend patient’s life. 
However, it also has brought severe psychosocial problems. 
Psychosocial problem such as anxiety, depression and high levels of 
stress has been shown in previous studies (Lim & Zebrack, 2006; 
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Foster et al., 2009). The fear of recurrence or relapse also factors the 
psychosocial problems that the patients experience (Tjemsland, Søreide, 
& Malt, 1998). It has been shown that patient experience 
psychological problems both during and after the completion of 
treatment (Palmer, Kagee, Coyne, & DeMichele, 2004) and 
psychological distress, has been found in 33~38% of those suffering 
from hematologic cancer (Persson et al., 2001). In previous study, it 
has been found that fear and uncertainty about the future were the 
most commonly identified cancer-related problems in patients with 
cancer and survivors (Sammarco & Konecny, 2008). These 
psychosocial problems lead patients with hematologic cancer to have a 
relatively low quality of life (Persson et al., 2001). 
Patients with cancer experience uncertainty as an extreme 
vulnerability and powerful urge to know what they will experience, 
whether or not they will survive, and if they survive, what quality of 
life and ability of function they will have in the future (Byar, Berger, 
Bakken, & Cetak, 2006). Uncertainty is the greatest source of 
psychological stress for patients affected by life-threatening illness 
(Christman et al., 1988). Higher levels of uncertainty are consistently 
associated with higher levels of emotional distress, reduced quality of 
life, and poorer psychosocial adjustment (Brennan, 2001; Lazarus, 
1986).
According to Mishel’s(1990) Uncertainty in Illness theory, 
people who experience uncertainty for a long time period develop 
symptoms such as those seen in people with posttraumatic stress 
disorder (PTSD). Patients with hematologic cancers, who may 
experience chronic uncertainty is at increased risk for posttraumatic 
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stress symptoms (PTSS). The diagnosis and treatment of cancer is a 
potentially traumatic experience that may lead to PTSS. The 
Diagnostic and Statistical Manual of Mental Disorders (DSM-V) notes 
that a life-threatening illness ‘is not necessarily considered a traumatic 
event’, but that medical incidents that are ‘sudden’ and ‘catastrophic’ 
may qualify, while DSM-IV states that ‘being diagnosed with a 
life-threatening illness’ was listed as a potentially traumatic event 
(American Psychiatric Association, 2000). 
There is an increased number of research that suggesting the 
diagnosis and treatment of cancer may lead to PTSS (Alter et al., 
1996; Brennan, 2001). Since PTSS is a significant psychological 
problem for some patients with cancer (Alter et al., 1996), it is 
important to investigate the prevalence in patients with hematologic 
cancer and the predictors of the development of this condition. 
The majority of research on cancer-related PTSS focuses on 
female patients with breast cancer. Less is known about the 
prevalence of PTSS in other cancer types or patient populations and 
one of the understudied group is the hematologic patients. Also, 
theory-based studies testing models predicting psychological outcomes 
for patient with hematologic cancers are limited. This study is guided 
by the Mishel’s Uncertainty in Illness Theory and Reconceptualization 
of Uncertainty in Illness Theory (Mishel, 1988, 1990).
In this study, the level of uncertainty, perceived social 
support, PTSS and psychological growth was measured to find the 
correlation between these variables. Little research has focused on the 
uncertainty and PTSS in patient with hematologic cancers. Research 
on the uncertainty in patients with hematologic cancers in Korea can 
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illuminate and broaden our understanding of the ways in which 
uncertainty is experienced in the relationship with PTSS and 
psychological growth.
2. Purpose of the Study
The purpose of this study was to identify the relationships 
among uncertainty, perceived social support, PTSS and psychological 
growth.
The specific aims were: (a) to explore the levels of 
uncertainty, perceived social support, PTSS and psychological growth 
experienced in patient with hematologic cancers in Korea, (b) to 
understand the relationships among uncertainty, perceived social 
support, PTSS and psychological growth.
 By assessing these level and relationships, the medical staff 
will be able to intervene prior to the development of posttraumatic 
stress disorder and other psychological problems in patients with 
hematologic cancer.
3. Definitions of Terms
1) Hematologic Cancer 
 Conceptual definition: Cancer that affects the body’s blood, bone 
marrow or lymphatic system. The most common forms of 
hematologic cancers include: leukemia (occurs when the bone 
marrow overproduces abnormal white blood cells, and is classified 
by the type of white blood affected: myeloid or lymphocytic), 
lymphoma (cancer of the lymphatic system that results in 
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uncontrolled growth of malignant white blood cells, forming 
tumors in the lymph nodes. Lymphoma is classified into two main 
types: Hodgkin’s and Non-Hodgkin’s lymphoma) (The Korean 
Society of Hematology, 2011). 
 Operational definition: The diagnosis of Acute Myeloid Leukemia 
(AML), Acute Lymphoblastic Leukemia (ALL), Chronic 
Myelogenous Leukemia (CML), Chronic Lymphocytic Leukemia 
(CLL), Myelodysplastic Syndrome (MDS), Hodgkin lymphoma, and 
Non-Hodgkin lymphoma by a medical doctor. 
2) Uncertainty 
 Conceptual definition: A cognitive state that occurs in situations 
where the patient is unable to assign definite values to events or 
objects and / or is unable to predict outcomes accurately because 
the cues are unpredictability, ambiguity, complexity, or lack of 
information (Mishel, 1984). 
 Operational definition: Scores on Mishel’s Uncertainty in Illness 
Scale – Community from (MUIS-C). The Korean version of 
MUIS-C was used in this study has been translated by Chung 
et.al to deliver a clearer meaning to the participants (Chung, Kim 
, Rhee, & Do, 2005).
3) Perceived Social Support 
 Conceptual definition: A perceived or actually help or support 
from others, which consists of four types of support: emotional 
support, integration, tangible help, and informational support 
(Krause & Markides, 1990). 
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 Operational definition: Scores on the Multidimensional Scale of 
Perceived Social Support measurement (Zimet, Dahlem, Zimet, & 
Farley, 1988). Korean version of the scale was used for the 
present study (Shin & Lee, 1999).
4) Posttraumatic Stress Symptoms 
 Conceptual definition: Complex set of behaviors and symptoms 
following perception of threat to loss of life including 
hypervigilance, hyperarousal, avoidant, and intrusive psychological 
effects (American Psychiatric Association, 2000). 
 Operational definition: Participant’s scores on the Posttraumatic 
Stress Disorder Checklist – Civilian version (Weathers, Litz, 
Herman, Huska, & Keane, 1993). This instrument has not been 
previously translated in Korean, so it was translated into Korean 
and the comparability of content was verified through 
back-translation procedures. 
5) Psychological Growth 
 Conceptual definition: A result of experiencing serious illness 
through which individuals relinquish their old life perspective and 
construct a new view of life (Mishel, 1990, 1999). 
 Operational definition: Participant’s scores on the Growth Through 
Uncertainty Scale (GTUS) (Mishel & Fleury, 1997). This 
instrument also has not been previously translated in Korean, so it 
was translated into Korean and the comparability of content was 
verified through back-translation procedures. 
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CHAPTER II. LITERATURE REVIEW
 It has been an area of interest to study the uncertainty in 
illness in patients living with illness since the early 1980’s. Nursing 
has focused on uncertainty as a main theme of research as well as an 
area needing assessment in clinical practice because the concept of 
uncertainty can be applied across different populations and may be 
worthwhile in explaining the responses to illness. With the 
development of instrument for measuring uncertainty in illness and the 
introduction of the mid-range nursing theory of uncertainty in illness 
by Mishel, many nursing research studies on uncertainty in different 
clinical populations and also in family members of patients have been 
conducted (Mishel & D. Epstein, 1997; Mishel, 1981).
1. Uncertainty with Cancer Continuum
A cancer diagnosis is threatening and it brings uncertainty. It 
can lead to pain, anxiety, unpredictable, and potentially negative 
outcomes. Furthermore, uncertainty continues in many cancer patient’s 
lives during the treatment and even after the treatment has ended 
because of the tenuous nature of remission, the possibility of relapse 
or recurrence, and the unknown and unpredictable after-effects of 
cancer and treatments (I. Lee, 2004; M. S. Lee, Kim, & Suh, 2008). 
Although long-term survival rates for cancer have shown dramatic 
improvements, uncertainty continues to be a prominent theme in 
research of cancer patient’s experience. 
The existing studies on cancer related psychosocial responses 
has shown the adverse effects of uncertainty on cancer patients’ 
well-being and has conceptualized uncertainty as a threat to 
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psychosocial well-being (I. Lee, 2004; Sammarco, 2001). 
In nursing, uncertainty was defined and conceptualized by 
Mishel (Mishel, 1981, 1988; Mishel & Braden, 1987). Scales for 
uncertainty in illness were developed for various populations; an adult 
form, a community form, a parent’s form, and a family member form 
measured uncertainty for different population. Uncertainty in illness 
was conceptualized as a multidimensional construct composed of 
ambiguity, unpredictability, complexity, and lack of information 
(Mishel & Braden, 1987). 
Among diverse demographic variables, age, education, and 
economic status have been often studied with uncertainty. Since those 
variables are associated with the degree of cognitive capacities for 
categorizing events, it is assumed that older, more highly educated 
persons or persons in a higher economic status perceive less 
uncertainty (Mishel, 1997). Education plays a primary role in 
providing a person’s knowledge base, better interpretation of 
symptoms (Mishel & Braden, 1988). 
Uncertainty results in the inability to have a clear conception 
of a stressful situation (Lazarus, 1986). Thus, uncertainty may effect 
either critical or non-critical areas of one’s life and may result in 
either serious or trivial consequences. Empirically, these positive and 
negative point of view regarding consequences of uncertainty are 
demonstrated in many research findings.
First, uncertainty may lead to a positive consequence when it 
allows reassuring interpretation of cues. Particularly in an illness 
situation, when a patient is unsure about the diagnosis or the severity 
of illness, it may enable the patient to assume that things will go 
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well (Mishel, 1990).
On the other hand, uncertainty may lead to negative 
consequences, uncertainty may cause a great deal of psychosocial 
stress. Increased uncertainty has been associated with increased stress 
(Mishel, 1990), more psychological mood disturbance (Christman et 
al., 1988), increased anxiety, lower level of life quality (Sammarco & 
Konecny, 2008), reduced coping effectiveness, and perception of 
diminished or lower health status (Sammarco, 2001). Therefore, 
uncertainty in illness has been identified as the single greatest source 
of psychosocial stress to patients. 
2. Perceived Social Support in Patients with Cancer
Social support is an important multidimensional construct 
effecting the patient’s ability to deal with the illness (Sjölander & 
Berterö, 2008). Social support, as one of the structure providers in 
Mishel’s model, has been included as a major variable in relation to 
uncertainty in illness in several research studies. Social support has 
been shown in the studies to be an intervening variable that helps to 
buffer stressful effects of illness (Ferrell, Smith, Ervin, Itano, & 
Melancon, 2003). Thus the presence of social support protects 
individuals encountering stressful life circumstances from physical and 
psychological disturbance (Kim & Lee, 2010). Studies in patients with 
cancer stated that social support was associated with better 
psychosocial adjustment to cancer (Sammarco, 2001). Social support 
may reduce uncertainty by modifying ambiguity concerning the state 
of illness, complexity perceived in treatment, and the unpredictability 
of the outcome and future (Mishel, 1990). Social support offers 
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feedback about the meaning of events, and discussing with significant 
others may facilitate a person’s ability to clarify uncertain events 
(Sammarco, 2003). 
Lower levels of social support significantly correlated with 
higher levels of uncertainty of illness in patients and family caregivers 
(Ferrell et al., 2003). Past studies used different valid and reliable 
instrument for measuring social support and the same uncertainty 
scale, they showed the same effect of social support on uncertainty in 
various clinical populations. A strong relationship between social 
support and uncertainty has been confirmed in several previous study 
(Sammarco, 2001, 2003; Sammarco & Konecny, 2008). 
Perceived social support is the information leading individuals 
to believe that they are cared for, loved, esteemed, and valued and 
belong to a network of communication (Huang, Wu, Zhang, Zhang, & 
Gao, 2010). Social support, particularly the support perceived from 
close, supportive relationships with spouse and family, may have 
significant impact on a person’s adjustment to cancer (Sjölander & 
Berterö, 2008). An individual’s perception of social support may be 
determined by the patient’s experiences with the world. Such 
experiences might include negative biases, affective symptoms, and 
anxiety symptoms and these experiences may change the way an 
individual interprets and processes information about external 
occurrences. 
Research has demonstrated that past perceived life threat, in 
addition to perceived and actual social support resources, can 
contribute to PTSS in cancer patient, survivors and in their family 
members (Alter et al., 1996). It was found that social support was 
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one of the variables that could longitudinally predict decreases in the 
PTSS involving avoidance and numbing (Andrykowski, Cordova, 
Mcgrath, Sloan, & Kenady, 2000a). 
3. Posttraumatic Stress Symptoms in Patients with Cancer
Many aspects of a cancer experience ranging from information 
delivery about the diagnosis, treatment, threat of recurrence, or the 
failure of treatment can have the potential of experiencing PTSS 
(Buonocore, 2004). Physical, cognitive and emotional changes can be 
left as life-long cancer experience. Some researchers stated that fear 
and horror typically peak at diagnosis, and also the potential for 
recurrence or actual recurrence of the cancer (Kangas, Henry, & 
Bryant, 2002). 
For example, prior to the experience of a trauma, such as 
being diagnosed with cancer, a person may believe that the world is 
a relatively predictable place, that they have control over their life; 
and the plans they have made for the future will come (Smith, Redd, 
Peyser, & Vogl, 1999). Whereas following the diagnosis and 
treatment, they may begin to realize, as a result of their cancer 
experience, that the world is not as predictable as they once thought 
and the plans they have made may not come. This can be extremely 
distressing and may lead directly to psychological distress as well as 
indirectly to increased physiological arousal through stimuli that 
remind them of the trauma of diagnosis and treatment including 
negative cognitions, intrusive thoughts, ongoing medical appointments, 
concerns about the future, and uncertainty about recurrence. 
Additionally, this response may lead to increased negative 
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psychological responses such as anxiety, negative affect, intrusive 
thoughts, catastrophic thinking, and intrusive thoughts, which may 
potentially lead to an increase in PTSS.
The Diagnostic and Statistical Manual of Mental Disorders, 
Fourth Edition (DSM-IV) (American Psychiatric Association, 2000) 
defines PTSD as an anxiety disorder that occurs following a traumatic 
event that involved actual or threatened death or a threat to one’s 
physical integrity or that of others, and which evoked intense fear, 
helplessness or horror. Diagnostic criteria include three symptom 
clusters: re-experiencing in the form of recurrent and intrusive 
thoughts, avoidance of or numbing in response to trauma-related 
stimuli, and increased physiological arousal. Criteria must be met for 
at least one month and cause clinically significant distress or 
impairment.
The DSM-IV expanded events capable of eliciting a response 
of PTSD, when compared to the previous editions, to include 
life-threatening illnesses such as cancer (American Psychiatric 
Association, 2000). The events that unfold during a cancer diagnosis 
and subsequent treatment are capable of producing symptoms of 
posttraumatic stress disorder (Kangas et al., 2002). PTSD and 
sub-syndromal PTSS are associated with higher rates of depression 
anxiety disorders (Dirkzwager, Bramsen, & VAN DER PLOEG, 
2001), and lower quality of life among cancer patients and survivors 
(Persson et al., 2001). Cancer patients who experience PTSS also 
appear to experience negative physical health outcomes, suggesting the 
need to examine the relationship between posttraumatic stress and 
physical health symptoms (Andrykowski et al., 2000a; Schwartz & 
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Drotar, 2006). For example, a study was done to explore the 
relationship between PTSD and psychological, physical health 
outcomes among childhood cancer survivors (Schwartz & Drotar, 
2006). They reported that higher levels of PTSS were associated with 
worse psychosocial health outcomes including poorer mood, more 
depressive symptoms, and worse health-related quality of life when 
compared with those with fewer PTSS (Schwartz & Drotar, 2006).
While the diagnosis of PTSD is somewhat rare among patients 
with some types of cancer (Kangas et al., 2002), posttraumatic stress 
symptoms may occur in up to 50% of all cancer patients (Gurevich 
et al., 2004). Considering the potentially deleterious effects of PTSS 
and the fact that incidence of cancer diagnosis continues to rise, 
cancer-related PTSS have the potential to negatively impact the lives 
of thousands of people (Jemal et al., 2007). 
Numerous studies have documented a link between PTSS and 
poorer medical prognosis, decreased immune system functioning, 
longer hospital stays, greater avoidance of medical follow-up, greater 
declines in compliance with professional recommendations, lower 
quality of life, increases in life-threatening behaviors, and increases in 
morbidity rates regardless of time elapsed since medical treatment 
when compared to non-psychologically distressed patients (Dirkzwager 
et al., 2001; Jacobsen et al., 2002). This condition cannot be expected 
to diminish over time in and onset can occur even months after 
diagnosis and treatment. Detection of PTSS can be reliably assessed 
using self-report measures or structured interviews. Self-report 
measures can be more efficient and convenient when assessing the 
symptoms in cancer patients (Horowitz, Wilner, & Alvarez, 1979).
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4. Psychological Growth in Patients with Cancer
More and more research has focused on psychological growth 
through traumatic experiences such as cancer. Although experiencing 
trauma and adversity can cause significant psychological and physical 
distress, exposure to a high level of stress does not always cause 
people to develop psychiatric disorders (Tedeschi & Calhoun, 1995). 
Research has shown that even though it is true that many people 
initially show stress-related symptoms after experiencing traumatic 
events, some of them demonstrate positive psychological changes and 
personal growth later on (Park, 2004; Tedeschi & Calhoun, 2004; 
Tedeschi, Tedeschi, Park, & Calhoun, 1998).
Based on Mishel’s Reconceptualization of the theory of 
uncertainty in chronic illnesses, a new worldview involving 
probabilistic and conditional thinking serves as a positive 
psychological outcome under continual uncertainty (Mishel, 1990). 
Patients with a chronic illness and their families can make a transition 
from a perspective of life oriented towards control to another one 
accepting uncertainty as the natural rhythm of life. By accepting 
continual uncertainty, patients are able to move towards a new view 
of life which includes reordering priorities, increasing flexibility, and 
expecting multiple possibilities (Mishel, 1990). 
Many qualitative studies have found that cancer patients 
experienced positive change and personal growth through illness-related 
uncertainty, but only a few studies (Bailey Jr et al., 2004; Mast, 
1998; Porter et al., 2006) have measured growth through uncertainty 
quantitatively and none of the studies were focused on hematologic 
cancer patients in Korea. In this study, psychological growth was 
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measured quantitatively by the instrument, Growth Through 
Uncertainty Scale (GTUS) (Mishel, 1997). Psychological growth is a 
dynamic process through illness experiences. Although the direct 
relationship between uncertainty and psychological growth is not 
proposed in Mishel’s Reconceptualization of Uncertainty in Illness 
Theory, the relationship between uncertainty and psychological growth 
through uncertainty was examined in this study (Mishel, 1990).
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CHAPTER III. THEORETICAL FRAMEWORK
The theoretical framework that guided this study was 
formulated from Mishel's middle range theory of Uncertainty in Illness 
(Mishel, 1988). The theory has been used as a main theoretical 
framework in many previous qualitative and quantitative studies with 
cancer population. Uncertainty is the inability of patient to determine 
the meaning of illness-related events such as their disease process, 
treatment, or hospitalization (Mishel, 1988). Uncertainty has four 
elements: ambiguity concerning the state of illness; lack of 
information about the illness, treatment, treatment effects, and effective 
management; complexity regarding the available information about the 
treatment, the system of care, and relationships with providers; and 
unpredictability of an individual's course of disease, prognosis, and 
future quality of life and level of function (Mishel, 1981; Mishel & 
Braden, 1988).
When symptoms form a pattern and events are recognized as 
familiar, a stimuli frame can be created to lessen uncertainty. A 
stimuli frame is the form, composition, and structure of stimuli in 
illness-related events (Mishel, 1988). According to the uncertainty in 
illness theory, structure providers such as credible authorities, social 
supports and education can positively affect the stimuli frame and 
reduce uncertainty directly and indirectly. Credible authority is defined 
as the degree of trust and confidence patients have in the health care 
providers (Mishel & Braden, 1988). Credible authority from nurses or 
physicians affects the formulation of the stimuli frame by providing 
information on the causes and consequences of symptoms, reducing 
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uncertainty indirectly. It was proposed that when the health care 
providers were evaluated as being highly credible, the uncertainty 
perceived by patients would be lessened (Mishel, 1988; Mishel & 
Braden, 1987).
As another structure provider, social support has been 
evaluated for its preventive effects on uncertainty both directly and 
indirectly (Mishel & Braden, 1987, 1988). Through social support 
system, patients can obtain or share information about their symptoms 
and establish a network where patient depends on another’s expertise 
to deal with various threatening events (Mishel, 1988). Social support 
has been shown to lessen uncertainty.
The third structure provider, education, is also related to 
uncertainty both indirectly and directly (Mishel & Braden, 1988). 
Education functions indirectly in relation to uncertainty by providing 
event associated knowledge that helps from an event structure in 
stimuli frame. Apparently, education directly influences uncertainty by 
assisting in the construction of meaning for events and by modifying 
uncertainty quickly. Therefore, less educated patients need more time 
to figure out the event, and they experience uncertainty for longer 
periods of time than more educated patients (Christman et al., 1988; 
Mishel & Braden, 1988).
Mishel reconceptualized her original theory to more adequately 
describe individual responses to chronic illness (Mishel, 1990). 
According to her reconceptualization, individuals can begin to see 
beneficial aspects of chronic uncertainty and develop probabilistic 
views of life with support from family, friends, and healthcare 
providers. Uncertainty is inherently neutral; it can be appraised as 
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either dangerous or beneficial. In acute illness and other extremely 
stressful situations in which the threat to life or the integrity to the 
self is perceived as being great, adults tend to appraise uncertainty as 
dangerous. When uncertainty is appraised as a danger and coping 
resources and environment are sufficient, individuals tend to take 
action to reduce uncertainty (Mishel, 1981). The development of a 
new view of life is a positive psychological adjustment (Mishel, 1999) 
and can be perceived as growth through uncertainty (Bailey Jr, 
Mishel, Belyea, Stewart, & Mohler, 2004). 
However, when uncertainty is appraised as a danger and 
coping resources are insufficient, individuals tend to focus coping 
efforts on reducing awareness of whatever generates uncertainty and 
controlling the distressing emotions (Stewart & Mishel, 2000). 
Although overall uncertainty diminishes over time, unpredictability 
persists as a source of distress. Higher levels of uncertainty are 
consistently associated with higher levels of emotional distress, 
reduced quality of life, and poorer psychosocial adjustment. Higher 
levels of distressing emotions predict less functional coping (Mishel, 
1997). People who experience chronic uncertainty develop symptoms 
such as those seen in persons with PTSD (Mishel, 1990). 
Posttraumatic stress symptoms can lead patients to be engaged in 
health-risk behaviors. For example, an individual may use alcohol or 
other sedating substances to reduce whatever is causing the uncertainty 
and to manage emotional distress.
On the basis of Mishel’s model, the relationships among 
uncertainty, perceived social support, PTSS and psychological growth 
was proposed in this study. Chronic uncertainty may be experienced 
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in the process of diagnosis, treatment and prognosis of hematologic 
cancer showing PTSS and/or psychological growth (Mishel, 1990; 
1999).
Figure 1. Theoretical model adapted from the Uncertainty in Illness 




The purpose of this study was to identify the relationships 
among uncertainty, perceived social support, posttraumatic stress 
symptoms and psychological growth. The specific aims are to explore 
the levels of uncertainty, perceived social support, PTSS and 
psychological growth experienced in hematologic cancer patients in 
Korea, to identify the relationships among uncertainty, perceived social 
support, PTSS and psychological growth.
1. Study Design
This study was a cross-sectional, descriptive, correlational, 
self-report survey design to examine the levels of uncertainty, 
perceived social support, PTSS and psychological growth and their 
relationships. Because the relationship between uncertainty, PTSS and 
psychological growth in hematologic patients has not been studied, a 
descriptive design was appropriate. 
2. Setting and Sample
The participants was recruited from the hematology in-patient 
unit and out-patient clinic at a University Hospital which is a tertiary 
medical center located in Seoul, Korea. 
A convenience sampling method was used to obtain 
participants for this study. In order to obtain a proper sample size 
which can reveal significant results, G-power program was used. In 
order to calculate a sample size, the significance level (alpha), effect 
size, and power must first be determined (Faul, Erdfelder, Buchner, & 
Lang, 2009). 
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First, the significance level for the study was set at an alpha 
level of .05, which means that there is 5% risk of making a Type I 
error, falsely rejecting a true null hypothesis. For this study, the 5% 
risk will not be directly harmful to the participants or potential target 
populations because the study is not associated with any manipulation 
of patient’s care or their environments. This level of alpha is the 
most acceptable value in behavioral science research (Cohen, 1988). 
Secondly, the effect size 0.3 was chosen on the basis of 
Cohen’s recommendation since data on the effect size of relationship 
between uncertainty and its associated concepts (perceived social 
support, posttraumatic stress symptoms) in patients with hematologic 
cancer were not available (Cohen, 1988). 
Lastly, a power of .80 was used because it is the minimum 
acceptable level (Cohen, 1988). Based on this information about the 
significance level (alpha), effect size, power, and the number of 
variables and covariates, the sample size of 82 was calculated using 
the G*Power program. Considering the participants drop outs during 
the study, 175 participants was approached for this study.
The criteria for inclusion in the study are as follows:
1) The participant must have been diagnosed with hematologic 
cancer by a medical doctor. Hematologic cancer includes Acute 
Myeloid Leukemia (AML), Acute Lymphoblastic Leukemia 
(ALL), Chronic Myelogenous Leukemia (CML), Chronic 
Lymphocytic Leukemia (CLL), Myelodysplastic syndrome 
(MDS), Hodgkin lymphoma and Non-Hodgkin lymphoma. 
2) The participant must be able to speak and read Korean in 
order to understand the study questionnaires and answer the 
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questions.
3) The participant must be an adult, age 19 or older.
Patients who meet these inclusion criteria were screened for the 
following exclusion criteria.
1) Anyone who had rapidly deteriorating physical health, acute 
confusional state or memory or cognition difficulty to complete 
the survey was excluded from the study.
2) Anyone who was mentally disturbed due to their mental health 
status also excluded from the study.
3. Data Collection Procedure
Data collection took place from July 29th to September 1st of 
2014. The participants for this study were recruited from the 
University Hospital by the investigator. The investigator identified the 
patients that meet the criteria. Once the participant’s eligibility was 
determined, the investigator approached the participants. At this time, 
the investigator briefly explained who she is and the purpose of the 
study, and the written summary of the study was be given. If the 
patient was interested in participating in the study, they received a 
self-administered questionnaires designed to assess uncertainty, 
perceived social support, and PTSS. The participants were instructed 
to answer the questionnaires with reference to their experience of 
cancer and not to make reference to pervious psychological disorder, 
other chronic illness experiences or previous trauma. In addition, 
information about their diagnosis and treatment and demographic 
profiles such as age, gender, marital status and religion was be 
obtained. Gathered data were used to describe the relationship between 
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Variables Instrument No. of Items
Uncertainty Mishel’s   Uncertainty in Illness 
Scale – Community Form (MUIS-C) 23
Perceived Social   
Support
Multidimensional   Scale of 
Perceived Social Support (MSPSS) 12
Posttraumatic 
Stress Symptoms
PTSD Checklist – Civilian version 
(PCL-C) 17
Psychological   
Growth
Growth Through   Uncertainty Scale 
(GTUS) 39
uncertainty, social support and PTSS.
Overall, 175 participants’ information were gathered during the 
study period. However, 9 cases were excluded; 6 because of 
inadequate information provided and 3 for the worsening of the 
participant’s general physical condition. Finally, data on 166 
participants were included in the final analysis. 78 participants were 
patients who were admitted on the hematologic unit and 88 patients 
who were reached at the outpatient clinic. 
4. Measures
The four main concepts for the study (uncertainty, perceived 
social support, posttraumatic stress symptoms, and psychological 
growth) was measured by four different instruments (Table 1).
Table 1. Study Concepts & Measurements
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1) Demographic variables
A questionnaire was given, collecting information on 
demographics (gender, age, marital status, economic status, education 
and religion), illness related characteristics (type of cancer, time since 
diagnosis, and time since treatment and type of treatment undergone, 
history of treatment for psychiatric disorder). In this study, the 
patient’s functional status or the medical chart information such as 
complete blood count (CBC) and other medical examination results 
were not included in the present study. The reason was that because 
hematologic cancer patients joined the study at all different course of 
their treatment. Patients who had been diagnosed for a longer period 
of time were likely to have more medical knowledge and information 
about the disease. 
2) Uncertainty
Mishel’s Uncertainty in Illness Scale-Community Form 
(MUIS-C) was used to measure the uncertainty in illness. The 
community version was developed in 1986 by Mishel and it was 
derived from the Mishel’s Uncertainty in Illness Scale (MUIS) 
developed in 1981 (Mishel & Epstein, 1997; Mishel, 1981). The 
MUIS-C is a 23-item-self-administered measure that uses a five-point 
Likert-type response format, ranging from 1 (strongly disagree) to 5 
(strongly agree). Scores for all items were summed. Scores can range 
from 23 to 115, with a midrange score of 69. The higher scores 
reflect higher levels of uncertainty (Mishel & Epstein, 1997). 
The MUIS-C has been utilized in many research studies on 
uncertainty in diverse populations, including patients with cancer, 
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myocardial infarction, atrial fibrillation, and renal disease (Arroll, 
Dancey, Attree, Smith, & James, 2012; Bailey et al., 2010; Chiou & 
Chung, 2012; Davis et al., 2013; Haisfield-Wolfe et al., 2012; Kang, 
2011; Mishel & Epstein, 1997). These previous studies have shown  
MUIS-C to be a reliable and valid instrument for measuring illness 
uncertainty across different diseases (Mishel, 1997). The reliability of 
the MUIS-C has been reported in the moderate to high range (α = 
.74-.92). For this study, the internal consistency was Cronbach’s alpha 
= 0.870. The construct validity was also supported by the MUIS-C in 
terms of its external associations with indicators of theoretically 
related variables. For example, mean uncertainty score has been shown 
to decrease with an increase in level of education across population 
subgroups (Mishel & Epstein, 1997). In women who were newly 
diagnosed with gynecological cancers, higher levels of uncertainty 
have been associated with more adjustment problems (Mishel, 
Hostetter, King, & Graham, 1984). The Korean version of MUIS-C 
that was used in this study has been translated by Chung et.al 
(Chung et al., 2005).
3) Perceived Social Support
Multidimensional Scale of Perceived Social Support (Zimet et 
al., 1988) was used to measure the social support in hematologic 
cancer patients. The MSPSS is a 12-item scale with a five point scale 
(from 1 = strongly disagree to 5 = strongly agree) with potential 
range of the total score of 12 to 60. This measures three sources of 
support with four questions each: support from family, friends and 
significant other. In this study, significant other was appointed as the 
medical staff, such as doctors and nurses. Adequate internal and 
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test-re-test reliability have been demonstrated as well as strong 
factorial validity and moderate construct validity. Factor analysis has 
demonstrated that respondents clearly differentiate between three 
sources of social support (family, friends, and a special other) (Zimet 
et al., 1988). Cronbach’s coefficient alphas have been obtained for the 
whole measure and for each subscale. The reliability for the entire 
measure was α =.88, and for significant other, family, and friends, the 
values were α =.91, α =.87, and α =.85, respectively. Test retest 
reliability for each of these same scales was .85, .75, and .72, 
respectively (Zimet et al., 1988).
The Korean version of MSPSS has already been developed, 
and its reliability has been proven. The Korean version has a five 
point scale, being different from the original one (Shin & Lee, 1999). 
In this study, significant other subscale is defined as the support from 
medical team (doctor, nurse and medical staff). For this study, the 
internal consistency was 0.879.
4) Posttraumatic Stress Symptoms
PTSS were assessed by using the PTSD Checklist – Civilian 
version (PCL-C) (F. Weathers, Huska, & Keane, 1991). The PCL-C is 
a 17-item scale of PTSD symptomatology questionnaire that 
corresponds directly to the DSM criteria for PTSD. Items on the 
PLC-C are rated on a four-point Likert-type scale with responses 
ranging from “Not at all” to “Extremely.” The PCL-C provides a 
continuous score (17-85) based on the quantity and severity of 
symptoms allowing it to assess the level of PTSS.
The PCL-C has three subscales assessing symptoms from the 
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three DSM-IV symptom clusters, namely re-experiencing, avoidance, 
and increased arousal. Examples of items on each of the three  
sub-scales include; Re-experiencing symptoms “Repeated, disturbing 
memories, thought, or images of a stressful experience?” and 
“Suddenly acting or feeling as if a stressful experience were 
happening again as if you were reliving it?”; Avoidance symptoms 
“Avoiding thinking about or talking about a stressful experience or 
avoiding having feelings related to it?” and “Feeling emotionally 
numb or being unable to have loving feelings for those close to you”; 
and; Increased arousal symptoms “Having physical reactions (e.g. heart 
pounding, trouble breathing, sweating) when something reminded you 
of a stressful experience?” and “Feeling jumpy or easily startled?”
The PCL-C has demonstrated good psychometric properties, 
including high internal consistency and retest reliability (Ruggiero, Del 
Ben, Scotti, & Rabalais, 2003), and convergent validity with other 
common PTSD symptoms measures (F. W. Weathers, Keane, & 
Davidson, 2001). The PCL-C has been used in research with cancer 
patient and survivors (Andrykowski, Cordova, Mcgrath, Sloan, & 
Kenady, 2000b; Morrill et al., 2008; Smith, Redd, DuHamel, 
Vickberg, & Ricketts, 1999). For this study, the internal consistency 
was 0.907. 
5) Psychological Growth
Psychological growth in this study was measured by the 
translation of 39-item Growth Through Uncertainty Scale (GTUS) 
(Mishel & Fleury, 1997). The GTUS measures psychological growth 
as a result of experiencing serious illness through which individuals 
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change their old life perspective and build a new view of life 
(Mishel, 1990). The GTUS is the first instrument designed to measure 
positive psychological changes and personal growth through 
illness-related uncertainty. This 39-item scale uses the 5-point, 
Likert-scale which ranges from 1= “totally disagree” to 6= “totally 
agree.”  The potential range of the score from 39 to 195. A total 
score is calculated by summing up scores on all the items, with 
higher scores indicating more psychological growth through uncertainty 
and the changes in life view.
Alpha coefficients for the total scale were .94 in a study of 
men with prostate cancer (Bailey Jr et al., 2004) and .95 in one study 
with breast cancer survivors (Porter et al., 2006) and .94 on another 
study with breast cancer survivors (Mast, 1998). For this study, the 
internal consistency was 0.929. Construct validity was also supported 
by the negative correlation with the Profile of Mood states Scale 
(POMS) (Mast, 1998). In this study, the GTUS was translated into 
Korean and the comparability of content was verified through 
back-translation procedures. 
5. Data Analysis
The data was analyzed by using the Statistical Package for 
Social Science (SPSS) software program, version 21.0. Descriptive 
statics were obtained for the socio-demographic and illness related 
characteristics, including age, marital status, educational level, 
socioeconomic state, employment status, type of cancer and treatment, 
uncertainty level (MUIS score), perceived social support (MSPSS 
score), posttraumatic stress symptoms (PCL-C score) and psychological 
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growth (GTUS score). For evaluating the relationship among 
attachment uncertainty, social support, PTSS and psychological growth, 
Pearson’s correlation coefficients were performed. Linear regression 
analysis was used to explore the predictors for PTSS and 
psychological growth. The significance level was set at 0.05.
6. Ethical Consideration
Approval from a University Hospital Institutional Review 
Board that the researcher is affiliated with for this study was obtained 
prior to participant recruitment (IRB number: H-1406-031-584). The 
investigator discussed the study with the eligible patients, before being 
asked to participate in the study, both verbal information and written 
information was given (the purpose and procedure of the study). At 
this time, the participants were informed that the participation is 
voluntary and that they are able to drop out of the study at any time. 
And that their decision to participate or not to participate in the study 
will not influence the care they receive at the hospital. If the patient 
agreed to participate in the study, he or she read the informed 
consent form, and were asked to sign the written consent form. A 
copy of the consent form was given to the participant. 
 Potential risks to the patients who participate in the study 
were not anticipated since any known medical or legal risks exist 
when gathering the data using a questionnaire. The participants 
received a small token for participating in the study however, strictly 
speaking, there are no other direct benefits for the participants, but 
the results of the study may help health providers understand the 
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phenomena of patient’s uncertainty and the study provided an 
opportunity for participants to express their perceptions and responses 
to hematologic cancer through the questionnaires.
The investigator protected the confidentiality of the participants 
by transcribing all data by code numbers. The only identifying 
information on the data was the code number and no names were 
attached to the questionnaires. All of the obtained data from the 
participants were only used for the purpose of the study. All of the 
collected data were entered into the computer, to which only the 
investigator has access, and the questionnaires for the study was 
destroyed upon completion of the study. Each participant were 
informed of the study procedure and how participant’s confidentiality 
will be protected, through the written consent form and verbal 
explanation by the investigator.
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CHAPTER V: RESULTS
1. Characteristics of the Participants
The demographic characteristics of the sample for this present 
study are shown on Table 1, including age, gender, education, 
employment, marital status, economic status and religion.
A total of 166 hematologic cancer patients participated for this 
study. Their mean age was 50.28 years old ranging from 19 to 82 
years old. Male participants were 105 (63.3%) and 61 female (36.7%) 
participated. Fifty percent (n=83) of the participants had a college or 
higher degree, 68 participants (41%) graduate high school and 15 
participants had went to middle school or less . Eighty-six participants 
were employed  (51.8%) and 80 participants (48.2%) were not 
employed. 120 participants were married (72.3%) and 46 participants 
were not married (27.7%) (Table 2). 
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Characteristics Category N (%) Mean 
(SDa)
Min-Max
Age (years) 20-30 38 (22.9)
50.28 
(14.97) 19 - 8240-50 84 (50.6)
≥60 44 (26.5)
Gender Male 105 (63.3)
Female 61 (36.7)
Education ≤ Middle school 15 (9.0)
High school 68 (41.0)
≥ College 83 (50)
Employment Employed 86 (51.8)
Unemployed 80 (48.2)
Marital status Single 46 (27.7)
Married 120 (72.3)
Economic status Good 10 (6.0)
Moderate 123 (74.1)
Low 33 (19.9)
Religion Yes 104 (62.7)
No 62 (37.3)
Table 2. Demographic Characteristics of the Participants      (N=166)
a standard deviation 
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Disease-related characteristics included the type of hematologic 
cancer, period since diagnosed, experience of relapse and if the 
patient is admitted on the unit, if the patient received bone marrow 
transplantation and if they ever experienced relapse of their disease 
are presented in Table 3.
Majority of the participants were diagnosed with Acute 
Myeloid Leukemia (AML) or Acute Lymphoblastic Leukemia (ALL) 
(n=79, 47.6%), 20 participants (12.0%) were diagnosed with Chronic 
Myelogenous Leukemia (CML) or Chronic Lymphocytic leukemia, the 
rest (n=67, 40.4%) were diagnosed with Myelodysplastic Syndrome or 
lymphoma. Less than 3 months since diagnosis was 27 participants 
(16.3%), more than 3 months to less than a year was 48 participants 
(28.9%), more than a year to 3 years was 47 participants (28.3%), 
more than 3 years was 44 participants (26.5%). 
19 participants (11.4%) did not receive bone marrow 
transplantation (BMT) and experienced relapse of their disease, 93 
participants (56.0%) did not receive bone marrow transplantation and 
also did not experience relapse, 25 participants (15.1%) did receive 
bone marrow transplantation and also experience relapse, 29 
participants (17.5%) received bone marrow transplantation and did not 
experience relapse. 
18 participants (10.8%) experienced relapse of their disease 
and were admitted on the unit, 58 participants (34.9%) did not 
experience relapse and were admitted on the unit, 23 participants 
(13.9%) experienced relapse and were not admitted on the unit, 67 
participants (40.4%) did not experience relapse nor admitted on the 
unit. 47 participants (28.3%) had other disease such as hypertension, 
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~ <3 27 (16.3)
28.91 
(37.14) 1 - 204
4~12 48 (28.9)
13~36 47 (28.3)




BMT(N) Relapse(N) 93 (56.0)
BMT(Y) Relapse(Y) 25 (15.1)
BMT(Y) Relapse(N) 29 (17.5)
Relapse and 
Admission
Relapse(Y) Admission(Y) 18 (10.8)
Relapse(N) Admission(Y) 58 (34.9)
Relapse(Y) Admission(N) 23 (13.9)







Other Disease Yes 47 (28.3)
No 119 (71.7)
diabetes, hyperlipidemia, hemorrhoid, and so on.
Table 3. Disease-related Characteristics of the Participants    (N=166)
a standard deviation 
b acute myeloid leukemia, c acute lymphoblastic leukemia
d chronic myelogenous leukemia, e chronic lymphocytic leukemia
f myelodysplastic syndrome
g bone marrow transplantation
h no(have not experienced), i yes(have experienced)
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Measures Mean ± SDa Range
Uncertainty 61.06 ± 13.64 31 - 94
Perceived Social Support 42.79 ± 8.10 12 - 60
Posttraumatic Stress Symptoms 44.02 ± 13.45 17 - 76
Psychological Growth 132.10 ± 20.39 63 - 186
2. Standardized Scores of Uncertainty, Perceived Social Support, 
Posttraumatic Stress Symptoms and Psychological Growth 
Uncertainty, the mean score for MUIS-C was 61.06(±13.64) 
with scores ranging from 31 to 94. Perceived social support, the mean 
score for MPSS was 42.79(±8.10) with scores ranging from 12 to 60. 
Posttraumatic stress symptoms, the mean score for PCL-C was 
44.02(±8.10) with scores ranging from 17 to 76. Psychological growth, 
the mean score for GTUS was 132.10(±20.39) with scores ranging 
from 63 to 186. 
Table 4. Standardized Scores of the Measures
  a standard deviation 
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Analyses were performed to determine whether the main study 
variables were significantly associated with demographic variables and 
disease-related characteristics.
1) Uncertainty by Characteristics of the Participants
ANOVA revealed that age and education level was 
significantly associated with uncertainty. Participants who were older 
than 60 years old experienced more uncertainty than participants age 
20 years to 39 years old or 40 to 59 years old. Participants who had 
lesser education than middle school experienced higher level of 







t or F p(Scheffe)





Sex Male 2.63 (0.59)
0.03 0.851
Female 2.69 (0.59)
Education ≤ Middle school 3.05 (0.49)
6.20 0.003*a>c
High school 2.72 (0.61)
≥ College
2.52 (0.55)
Employment Employed 2.52 (0.61)
1.93 0.167
Unemployed 2.79 (0.53)










Religion Yes 2.62 (0.60)
0.09 0.754
No 2.70 (0.57)
Table 5. Uncertainty by Demographic Characteristics of the 
Participants                                             (N=166)
* coefficients significant at p<.05
a standard deviation 
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It also showed that the period since the diagnosis of 
hematologic cancer, if the participant received bone marrow 
transplantation and experienced relapse, if the participant experienced 
relapse and admitted in the hospital, whether if the patient has 
another medical condition was significantly associated with uncertainty. 
Participants who have been 13 to 36 months since diagnosis 
experienced more uncertainty than participants who have been less 
than 3 months of diagnosis. It has shown that participants who did 
not receive bone marrow transplantation and experienced relapse of 
their disease had higher levels of uncertainty than participants who 
did not receive bone marrow transplantation and also did not 
experience relapse of their disease. Participants who did not 
experience relapse of their disease and are admitted in the hospital 
had lower levels of uncertainty than who experienced relapse and not 
admitted in the hospital. And participants who experienced relapse and 
not admitted in the hospital had higher levels of uncertainty than 
participants who did not experience relapse nor admitted in the 





























BMT(N)   Relapse(N) 2.53 (0.55)
BMT(Y)   Relapse(Y) 2.89 (0.49)
BMT(Y) Relapse(N) 2.62 (0.66)
Relapse and
Admission
Relapse(Y) Admission(Y) 2.81 (0.62)
5.03 0.002*b<c, c>d
Relapse(N) Admission(Y) 2.59 (0.61)
Relapse(Y) Admission(N) 3.03 (0.51)






2.80 (0.64) 0.00 0.967
Other Disease Yes 2.72 (0.66)
4.57 0.034*
No 2.62 (0.56)
Table 6. Uncertainty by Disease-related Characteristics       (N=166)
* coefficients significant at p<.05
a standard deviation 
b acute myeloid leukemia, c acute lymphoblastic leukemia
d chronic myelogenous leukemia, e Chronic lymphocytic leukemia
f myelodysplastic syndrome
g bone marrow transplantation
h no(have not experienced), i yes(have experienced)
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Characteristics Category
Perceived Social   Support
Mean (SDa) t or F
p
(Scheffe)
Age (years) 20-39 3.88 (0.66)
2.44 0.09040-59 3.91 (0.75) 
≥ 60 3.61 (0.78)
Sex Male 3.78 (0.71)
0.78 0.377
Female 3.90 (0.81)
Education ≤ Middle school 3.48 (0.89)
3.33 0.038*c>aHigh school 3.74 (0.71)
≥ College 3.96 (0.73)
Employment Employed 3.88 (0.70)
1.57 0.211
Unemployed 3.76 (0.79)
Marital status Single 3.75 (0.82)
0.66 0.417
Married 3.85 (0.72)
Economic status Good 4.04 (0.57)
1.01 0.365Moderate 3.84 (0.75)
Low 3.68 (0.77)
Religion Yes 3.87 (0.80)
1.75 0.187
No 3.75 (0.65)
2) Perceived Social Support by Characteristics of the Participants
ANOVA revealed that education level was significantly 
associated with the level of perceived social support. Participants with 
a college degree or higher had higher level of social support than 
participants with education less than middle school (Table 7).
Table 7. Perceived Social Support Demographic Characteristics of the 
Participants                                             (N=166) 
* coefficients significant at p<.05
a standard deviation 
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It also showed that type of cancer and period since diagnosis 
was significantly associated with the level of perceived social support. 
Participants diagnosed with AML and ALL had higher levels of social 
support than participants diagnosed with CML and CLL. Participants 
diagnosed less 3 months ago had higher levels of social support than 
participants diagnosed more than 3 years ago (Table 8).
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Characteristics Category
Perceived Social   Support
Mean 
(SDa)

























BMT(N) Relapse(N) 0.73 (0.76)
BMT(Y) Relapse(Y) 0.58 (0.11)
BMT(Y) Relapse(N) 0.75 (0.14)
Relapse and
Admission
Relapse(Y) Admission(Y) 3.68 (0.67)
2.61 0.053
Relapse(N) Admission(Y) 4.02 (0.69)
Relapse(Y) Admission(N) 3.56 (0.81)






3.79 (0.77) 0.14 0.700
Other Disease Yes 3.77 (0.70)
0.38 0.535
No 3.85 (0.77)
Table 8. Perceived Social Support by Disease-related Characteristics   
                                                      (N=166)
* coefficients significant at p<.05
a standard deviation 
b acute myeloid leukemia, c acute lymphoblastic leukemia
d chronic myelogenous leukemia, e chronic lymphocytic leukemia
f myelodysplastic syndrome
g bone marrow transplantation
h no(have not experienced), i yes(have experienced)
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Characteristics Category
Posttraumatic   Stress 
Symptoms
Mean (SDa) t or F
p
(Scheffe)
Age (years) 20-39 2.40 (0.85)
4.32 0.015*c>a40-59 2.52 (0.76)
≥60 2.87 (0.71)
Sex Male 2.56 (0.78)
0.01 0.893
Female 2.63 (0.81)
Education ≤ Middle school 2.74 (0.85)
0.30 0.738High school 2.56 (0.75)
≥ College 2.58 (0.81)
Employment Employed 2.52 (0.75)
0.90 0.343
Unemployed 2.65 (0.82)






0.64 0.526Moderate 2.57 (0.76)
Low 2.70 (0.86)
Religion Yes 2.61 (0.82)
2.21 0.138
No 2,54 (0.73)
3) Posttraumatic Stress Symptoms by Characteristics of the Participants
Age was significantly associated with the level of PTSS. 
Participants older than 60 years old had higher levels of PTSS than 
participants’ age from 20 to 39 years old (Table 9).
Table 9. Posttraumatic Stress Symptoms by Demographic 
Characteristics of the Participants                          (N=166)
* coefficients significant at p<.05





Mean (SDa) t or F p




















BMT(N)   Relapse(N) 0.75 (0.07)
BMT(Y)   Relapse(Y) 0.68 (0.13)
BMT(Y) Relapse(N) 0.92 (0.17)
Relapse and
Admission
Relapse(Y) Admission(Y) 2.75 (0.88)
2.15 0.095
Relapse(N) Admission(Y) 2.40 (0.81)
Relapse(Y) Admission(N) 2.83 (0.63)






2.97 (0.60) 2.85 0.093
Other Disease Yes 2.62 (0.83)
0.42 0.516
No 2.57 (0.77)
None of the disease-related characteristics were significantly 
associated with posttraumatic stress symptoms (Table 10).
Table 10. Posttraumatic Stress Symptoms by Disease-related 
Characteristics                                          (N=166)
a standard deviation 
b acute myeloid leukemia, c acute lymphoblastic leukemia
d chronic myelogenous leukemia, e chronic lymphocytic leukemia
f myelodysplastic syndrome
g bone marrow transplantation
h no (have not experienced), i yes (have experienced)
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Characteristics Category
Psychological   Growth
Mean (SDa) t or F p
Age (years) 20-39 3.38 (0.38)
1.72 0.18240-59 3.44 (0.56)
≥60 3.26 (0.53)
Sex Male 3.35 (0.50)
0.33 0.563
Female 3.43 (0.54)
Education ≤ Middle school 3.13 (0.73)
2.26 0.107High school 3.37 (0.54)
≥ College 3.44 (0.44)
Employment Employed 3.44 (0.56)
1.19 0.277
Unemployed 3.32 (0.46)






3.04 0.050Moderate 3.39 (0.48)
Low 3.26 (0.56)
Religion Yes 3.38 (0.54)
1.18 0.278
No 3.38 (0.48)
4) Psychological Growth by Characteristics of the Participants
None of the general characteristics and disease-related 
characteristics was significantly associated with psychological growth 
in patients with hematologic cancer (Table 11).
Table 11. Psychological Growth by Demographic Characteristics of the 
Participants                                             (N=166)
a standard deviation 
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Characteristics Category
Psychological   Growth












Diagnosis   
(months)




< 36 ~ 3.44 (0.48)
BMTg and 
Relapse
BMT(Nh) Relapse(Yi) 0.39 (0.91)
1.12 0.339
BMT(N) Relapse(N) 0.50 (0.05)
BMT(Y) Relapse(Y) 0.52 (0.10)
BMT(Y) Relapse(N) 0.60 (0.11)
Relapse and
Admission
Relapse(Y) Admission(Y) 3.19 (0.39)
1.38 0.250
Relapse(N) Admission(Y) 3.47 (0.56)
Relapse(Y) Admission(N) 3.40 (0.57)






3.14 (0.51) 0.00 0.996
Other Disease Yes 3.44 (0.52)
0.00 0.944
No 3.36 (0.52)
None of the disease-related characteristics was significantly 
associated with psychological growth in patients with hematologic 
cancer (Table 12).
Table 12. Psychological Growth by Disease-related Characteristics     
                                                      (N=166)
a standard deviation 
b acute myeloid leukemia, c acute lymphoblastic leukemia
d chronic myelogenous leukemia, e chronic lymphocytic leukemia
f myelodysplastic syndrome
g bone marrow transplantation
h no(have not experienced), i yes(have experienced)
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Variables




0.486   
(<0.000)*
-0.254   
(<0.001)*
PSS -0.441   
(<0.000)*
0.413   
(<0.000)*
PTSS -0.295   
(<0.000)*
3. Correlations between Uncertainty, Perceived Social Support, 
Posttraumatic Stress Symptoms and Psychological Growth
A significant positive correlation was noted between 
uncertainty and PTSS, r =0.486, p <0.000. A significant positive 
correlation was also found between perceived social support and 
psychological growth, r = 0.413, p <0.000. A significant negative 
correlation was found between uncertainty and social support, r = 
-0.383, p <0.000. Significant negative correlation was also found 
between uncertainty and psychological growth, r = -0.254, p <0.001. 
Significant negative correlation was also found between social support 
and PTSS, r = -0.441, p <0.000 and PTSS also had a negative 
correlation with psychological growth, r = -0.295, p <0.000 (Table 
13).   
Table 13. Correlations between Uncertainty, Perceived Social Support, 
Posttraumatic Stress Symptoms and Psychological Growth
* coefficients significant at p<.05




B SE β t p Tolerance VIF
(constant) 2.473 .446 5.542 .000
Uncertainty .496 .094 .372 5.290 .000 .853 1.172
PSSa -.314 .074 -.298 -4.237 .000 .853 1.172
R square .312




4. Factors influencing Posttraumatic Stress Symptoms
A Stepwise multiple regression was performed using 
uncertainty and perceived social support to predict posttraumatic stress 
symptoms. In the first step, uncertainty was entered and predicted 
23.6% of the variance of the PTSS scores. Perceived social support 
entered the second step and predicted 7.6% of additional variance of 
PTSS. Together these two variables predicted 31.2% of the variance 
of PTSS. Coefficients from the second step of the regression model 
indicated that increased uncertainty was associated with higher levels 
of PTSS and decreased perceived social support was associated with 
higher levels of PTSS (Table 14).
Table 14. Stepwise Multiple Regression Analysis for Posttraumatic 
Stress Symptoms
a perceived social support
Note. Uncertainty, perceived social support, age and education were analyzed as 





B SE β t p Tolerance VIF
(constant) 2.743 .311 8.808 .000
PSSa
.274 .048 .395 5.676 .000 .987 1.013
BMT & 
Relapse .089 .040 .154 2.227 .027 .998 1.002
Psychological 
Treatment -.278 .130 -.148 -2.137 .034 .996 1.004
Economic 
status -.149 .074 -.140 -2.004 .047 .985 1.015
R square .231




5. Factors influencing Psychological Growth
A Stepwise multiple regression was performed using perceived 
social support, economic status, bone marrow transplantation or 
relapse, and psychological treatment to predict psychological growth. 
In the first step, perceived social support was entered and predicted 
17.1% of the variance of the psychological growth. Bone marrow 
transplantation or relapse predicted 2.0%, psychological treatment 
predicted 2.1%, economic status predicted 1.9% of the additional 
variance of psychological growth. Together these four variables 
predicted 23.1% of the variance of psychological growth (Table 15).
Table 15. Stepwise Multiple Regression Analysis for Psychological 
Growth
a perceived social support
Note. Uncertainty, perceived social support, economic status, bone marrow 
transplantation or relapse and psychological treatment were analyzed as independent 
variables. Uncertainty was excluded by stepwise method
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CHAPTER VI. DISCUSSION
The findings of the study provide a description of the 
relationship between uncertainty, perceived social support, posttraumatic 
stress symptoms and psychological growth in Korean patients with 
hematologic cancers. Uncertainty, social support, PTSS and 
psychological growth in patients with hematologic cancers were shown 
to have a significant correlation, to support the theoretical model 
proposed in this study.
In the present study, the mean score of uncertainty in patients 
with hematologic cancers were 61.06±13.64, the average score for 
each item was 2.65±0.59. Other study done by Kim (2008) with 
breast cancer survivors in Korea using the same scale, the average 
score for each item of uncertainty was 1.87 (Kim, 2008). Patients 
with hematologic cancers showed similar levels of uncertainty 
compared to patients with different types of cancer. Due to the 
special characteristics of the disease, patients are not given the time 
to be prepared for their treatment. As soon as the patient is 
diagnosed with hematologic cancer, most of the patients are admitted 
in the hospital and treated as soon as possible. Even after the 
treatment, patients continuously visit the hospital, which may increase 
their level of uncertainty than other disease. 
In this study, participant’s age was significantly associated 
with uncertainty level. Older participants had higher levels of 
uncertainty in illness. As Mishel (1983) indicated that education level 
might influence uncertainty, this study showed the same results. 
Participants with higher levels of education had lower levels of 
uncertainty. However, there is conflicting evidence in other previous 
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study, stating that education is not significantly associated with the 
levels of uncertainty in adult cancer patient (Porter et al., 2006; 
Wonghongkul, Moore, Musil, Schneider, & Deimling, 2000). Even 
though education is a resource assisting patients to explain and assign 
meaning to illness-related situations (Mishel, 1998), more research is 
needed to clarify how education functions as a structure provider to 
decrease illness-related uncertainty in patients with cancer. Longer the 
patient live with cancer, they felt higher levels of uncertainty. Patients 
who had other disease besides the hematologic cancer had higher 
levels of uncertainty. Patients who received bone marrow 
transplantation and experienced relapse had lower levels of uncertainty 
than patients who did not received bone marrow transplantation and 
experienced relapse of their disease. 
Patients who did not experience relapse of their disease and 
admitted in the hospital had lower levels of uncertainty than patients 
who experienced relapse and was not admitted in the hospital. Patient 
who experienced relapse and was not admitted in the hospital had 
higher levels of uncertainty than patients who did not experience 
relapse nor admitted in the hospital. This showed that patients who 
experienced relapse had higher levels of uncertainty regardless of the 
patient’s hospital admission.   
In this study, higher uncertainty was associated with more 
PTSS, to support the re-conceptualization of Uncertainty in Illness 
theory (Mishel, 1990). This relationship could be explained from the 
perspective of re-conceptualization of Uncertainty in Illness Theory; 
people with chronic uncertainty in illness may adopt PTSS as a way 
to manage their uncertainty when they lack sufficient resources for 
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coping with the challenges of survivorship (Mishel, 1990).
The mean score of perceived social support in hematologic 
cancer patient were 42.79±8.10 and the average score for each item 
was 3.82±0.75. Compared to a study done with a sample of Korean 
patients with breast cancer (mean score: 43.82 ±7.56), it showed 
slightly lower levels of social support. This could be that the patients 
with hematologic cancers are isolated due to their extremely low 
immune system, which limits the visitors while they are in the 
hospital. PTSS in patient with hematologic cancers can be reduced 
through reducing their uncertainty by providing information about the 
occurrence and severity of late effects, clarifying their ambiguity about 
their illness state, decreasing the complexity of the health care system, 
and increasing their ability to exert some control over the 
unpredictability of their life in terms of its quality in the future and 
their level of function.
Social support was also significantly positively associated with 
the level of education. Participants with higher degree of education 
had higher level of social support. Participants who were diagnosed 
with Acute Myeloid Leukemia and Acute Lymphoblastic Leukemia 
had higher levels of social support than participants diagnosed with 
Chronic Myelogenous Leukemia and Chronic Lymphocytic Leukemia. 
This might be related to their survival time. As soon as the 
participants are diagnosed with their disease, family and friends may 
give their full attention, however, as time pass with longer survival 
time, the attention from support sources may be dispersed. This 
explains why the higher levels of perceived social with participants 
diagnosed within 3 months than participants diagnosed more than 3 
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years.
In the present study, more perceived social support was 
associated with lower uncertainty. The research finding is consistent 
with Mishel’s (1988) Uncertainty in Illness Theory. Social support can 
directly influence uncertainty by providing information by decreasing 
ambiguity, complexity, or unpredictability of illness-related situations 
(Mishel, 1983, 1988).
 The research findings showed that participants’ perceived 
social support had a significant influence on psychological growth and 
posttraumatic stress symptoms. More social support with higher levels 
of psychological growth and lower levels of posttraumatic stress 
symptoms.
In this study, PTSS was predicted 33.3% with the variables of 
uncertainty, social support and education level. And psychological 
growth was predicted 23.1% with the variables of social support, 
whether the participant received bone marrow transplantation or 
experienced relapse of their disease, if the participant received 
psychological treatment, and economic status. The variable that most 
affected a posttraumatic stress symptom was uncertainty and the 
variable that most affected a psychological growth was perceived 
social support. Since, the Mishel’s Uncertainty in Illness Scale – 
Community (MUIS-C) and Growth through Uncertainty Scale (GTUS) 
was not a measure specifically designed to measure uncertainty in 
patients with cancer, more research is needed. With more specific 
scale, the prediction could be higher for PTSS and psychological 
growth. 
This study is meaningful since it did not just measure PTSS 
-54-
which could be shown was a negative outcome, but also measured 
the positive outcome, psychological growth in patients with cancer. 
Recently in Korea, PTSS due to trauma has unfortunately been a big 
issue since the Sewol Ferry disaster in April, 2014. The psychological 
growth trough trauma should be highlighted for the survivors and a 
close monitoring should be done. Hopefully, the PCL-C, GTUS scale 
that has been translated and back-translated to verify the validity 
through the process of this study could be a useful source to help the 
survivors of Sewol Ferry survivors, future patients with cancer and 
other trauma experienced group of people.
Based on these results, interventions that are intended to 
decrease posttraumatic stress symptoms and to increase psychological 
growth in patients with hematologic cancers, possibly targeting 
uncertainty and social support are needed. Although there are no 
known psychosocial interventions developed specifically for patients 
with hematologic cancers, evidence-based offerings could be developed 
to meet the special needs of this population. The Managing 
Uncertainty Day-to Day intervention is designed to help older breast 
cancer survivors manage fears of recurrence and improve coping skills 
by delivering cognitive strategies via audiotape (Mishel, 2005). 
Supportive-expressive group therapy intervention also has been shown 
to significantly reduce trauma symptoms and mood disturbance in 
women with advanced breast cancer (Classen, 2001). These treatments 
exist for other types of cancer and these interventions may be 
beneficial for the patients with hematologic cancers PTSS and 
psychological growth.
There were several limitations in the present study. First, 
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although the instruments used in the study generally demonstrated 
acceptable reliability coefficients. The convenience sample of Korean 
patients with hematologic cancers contained an overrepresentation of 
married male, which may not be representative of patients with 
hematologic cancers throughout Korea. The likelihood of sampling 
bias possibly could skew participants’ scores on the variables. 
Therefore, results should not be generalized beyond the study sample. 
With regard to sampling, the sample size was sufficient to 
gain enough power. However, the participants were not chosen from a 
random sample. All patients who participated in this study were 
recruited from Seoul National University Hospital, a major medical 
center in Seoul, Korea. The non-random selection of participants may 
affect the sample’s representation of the total population thus limiting 
the generalizability of the research findings. In addition, patients who 
refused to participate in the study might have had unknown 
characteristics that could have influenced the study results. 
Another limitation of the research design was that it study 
was a cross-sectional study. The cross-sectional design does not allow 
for definitive explanation of casual relationships. Successful adaptation 
to a serious chronic illness is a process changing over time. Because 
the cancer experience is a learning process, longitudinal study is 
recommended for best study results.
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CHAPTER VII. CONCLUSION
In this study patient with hematologic cancers’ uncertainty 
were significantly associated with posttraumatic stress symptoms and 
significantly negatively associated with perceived social support and 
psychological growth. This result is the same as what has been 
explained in the re-conceptualized Mishel’s Uncertainty in Illness 
Theory. 
Significant correlations were identified among all four 
variables. As a result of multiple regression analysis, uncertainty and 
perceived social support were discovered to account for 31.2% of the 
variance in posttraumatic stress symptoms. Perceived social support, 
bone marrow transplantation or relapse, psychological treatment, and 
economic status were discovered to account for 23.1% of the variance 
in psychological growth. The variable that most affected a 
posttraumatic stress symptom was uncertainty and the variable that 
most affected a psychological growth was perceived social support.
There is not much literature on uncertainty, perceived social 
support, PTSS and psychological growth for cancer, especially in 
patients with hematologic cancers and Korean patients with cancer. 
More attention should be paid toward elaborating the view of 
uncertainty as a key element in the relationship between symptoms of 
PTSS and psychological growth in the future. 
Findings from the current study can enrich knowledge in 
nursing education about applying the Uncertainty in Illness Theory 
and its Reconceptualization (Mishel, 1988; 1990) in nursing care of 
hematologic patients and potentially for patients with other cancer. 
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Nurses who work with patients with hematologic cancers should 
develop an awareness of the uncertainty that permeates patient’s 
experience and that could develop to posttraumatic stress symptoms. 
Hematology unit nurses should be able to identify high-risk patients 
and intervene. 
Directions for Future Research
It is clear that more research on posttraumatic stress symptoms 
and psychological growth in patients with hematologic cancers are 
needed. This study is considered as an initial step in understanding 
the positive and negative psychological outcomes of living with 
continuous uncertainty about their disease. 
This study was a cross-sectional study so, future research 
employing a longitudinal design may be the best attempt to overcome 
the limitations of recall bias and casual ordering, In addition, 
qualitative interview are likely to provide a more rich understanding 
of patients with hematologic cancer uncertainty, social support, 
posttraumatic stress symptoms and psychological growth. Further 
research should be done on the development and testing of early 
intervention programs targeted for hematologic cancer patients.
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APPENDIX A: Informed Consent
안 하십니 ?
는 울 학  간호 학 사과 에 재학  지연 니다.
본 문지는 병동 나 래에  혈액암  치료 는 환 들  지각하는 확
실 , 사회  지지  상 후 스트 스  도  악하여 보다 나  간호 비스  공
하고  사하는 것 니다.
귀하께  답해주신 내  순수하게 연  만  것 고, 무
 처리  체  사항  비  지  약  드립니다.
귀하  직하고  는 답변 탁 드립니다. 
들고 편하신 에도 귀한 시간 내어주시고 답에 참여해 주  진심
 감사 드립니다.
연 : 지연 ( 울 학  간호 학 학원 사과 생)
: 울 학 병원
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연  참여 동
연  : 혈액암 환  확실 , 사회  지지, 상 후 스트 스 상과 
본 연 는 혈액암  진단  환 가 지각하는 확실 , 사회  지지, 상 후 
스트 스 상과  악하  해 마  것 니다. 문지  문 들  답  없
 여러  가지고 는 생각 그  문항에 답해 주시  니다.
문지는 하는   15~20  도 니다. 또한, 문지  하시는 도
에라도   원하지 않 실 경우에는 언 든지 그만 실 수 습니다.
공해주신 든 료  보는 무  처리 , 체 상 에 한 결과  
시 고 개별 는 시 지 않 므  체  사항  비  보 어, 귀하에게 어
한 도 생하지 않  것 니다. 또한 공해주신 보는 본 연 만 사
 것 ,  도 는 사 지 않  것 니다. 
귀하  답해주신 내  통해 혈액암  치료 는 환 들  확실 과 상 후 
스트 스 상들  악하여, 보다 나  간호 비스  공하는  도움   것 니다. 
연  하여 문사항  실 경우, 언 든지 아래  연락처  문 하시  
랍니다. 
연 : 지연( 울 학  간호 학 학원 사과 생)
: 울 학 병원  
본   연 에 하여 한   들었 ,  연 에 참여할 것  동
합니다. 본    연 에 참여하고  알고 습니다.
날짜:   2014     월    
:                ( )
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APPENDIX B: Demographic Information
ID #:
1.  Age: (   )
2.  Gender: Male(   ), Female(   )
3.  Education : below middle school(  ), high school(  ), college(  ), above college(  )
4.  Employment: Full time job(  ), Part-time job(  ), Not employed(  )
5.  Marital status: Single(  ), Married(  ), Widowed(  ), Divorced(  )
6.  Economic status: High(  ), Middle(  ), Low(  )
7.  Religion: Yes(  ), No(  )
8.  Type of cancer:
AML(  ), CML(  ), ALL(  ), CLL(  ), MDS(  ) 
Non-Hodgkin’s lymphoma(  ), Hodgkin’s lymphoma(  )
9.  Time since diagnosis: (  ) years (  ) months
10. Time since treatment: (  ) years (  ) months
11. Type of treatment undergone: 
Chemotherapy(  ), Radiation(  ), 
Bone marrow transplantation(allo(  ), auto(  ) ), Target therapy(  )
12. Have you experienced recur or relapse? Yes(  ), No(   )
13. Are you admitted in the hospital right now? Yes(  ), No(  ) 
14. History of treatment for psychiatric disorder: 
Yes(  ), No(  ) if yes, what is it?                         
15. Any other medical condition? Yes(  ) No(  ) if yes, what is it?                 
16. Is there a cancer patient in your family? 
Yes(  ), No(   ) if yes, who is it and what type of cancer is it?                 
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 특  문지
ID #:
1) 나 : (   )
2) 별: 남 (   ), 여 (   )
3) 도 : 하(  ), 고 (  ), (  ), 학원 상(  )
4) 직업: 규직(  ), 계약직(  ), 무직(  )
5) 결혼상태: 미혼(  ), 혼(  ), 사별(  ), 혼(  )
6) 경 상태: 상(  ), (  ), 하(  )
7) : 다(  ), 없다(  )
8) 진단  혈액암  :
AML(  ), CML(  ), ALL(  ), CLL(  ), MDS(  ) 
Non-Hodgkin’s lymphoma(  ), Hodgkin’s lymphoma(  )
9)  혈액암  진단  지 얼마나 었습니 ? (  )  (  )개월
10) 혈액암 치료   시 한지 얼마나 었습니 ? (  )  (  )개월
11) 어 한 혈액암 치료  습니 ? 
항암  치료(  ), 사  치료(  )
혈 포 식( 동 (  ), 가(  ) ), 치료 (   )
12) 혈액암  재   습니 ? (  ), 아니 (  )
13) 현재 병원에 원 십니 ? (  ), 아니 (  ) 
14) 신과 진단  거나 치료    습니 ? 없다(  ), 다(  ) 
다 , 어  진단  고 치료 습니 ?                      
15) 앓고 는 다  질병  습니 ? (  ), 아니 (  ) 
다 , 무엇 니 ?                                                
16) 가   암환 가 습니 ? (  ), 아니 (  ) 
















1. I don’t know what is wrong with me. 1 2 3 4 5
2. I have a lot of questions without answers. 1 2 3 4 5
3. I am unsure if my illness is getting better or worse. 1 2 3 4 5
4. It is unclear how bad my plan will be. 1 2 3 4 5
5. The explanations they give about my condition seem 
   hazy to me. 1 2 3 4 5
6. The purpose of each treatment is clear to me. 1 2 3 4 5
7. My symptoms continue to change unpredictably. 1 2 3 4 5
8. I understand everything explained to me. 1 2 3 4 5
9. The doctors say things to me that could have many  
   meanings. 1 2 3 4 5
10. My treatment is too complex to figure out. 1 2 3 4 5
11. It is difficult to know if the treatments or medications 
    I am getting are helping. 1 2 3 4 5
12. Because of the unpredictability of my illness, I cannot 
    plan for the future. 1 2 3 4 5
13. The course of my illness keeps changing. I have   
    good and bad days. 1 2 3 4 5
14. I have been given many differing opinions about what 
    is wrong with me. 1 2 3 4 5
15. It is not clear what is going to happen to me. 1 2 3 4 5
16. The results of my tests are inconsistent. 1 2 3 4 5
17. The effectiveness of the treatment is undetermined. 1 2 3 4 5
18. Because of the treatment, what I can do and cannot do 
    keeps changing. 1 2 3 4 5
19. I’m certain they will not find anything else wrong 
    with me. 1 2 3 4 5
20. The treatment I am receiving has a known probability 
    of success. 1 2 3 4 5
21. They have not given me a specific diagnosis. 1 2 3 4 5
22. The seriousness of my illness has been determined. 1 2 3 4 5
23. The doctors and nurses use everyday language so I   
    can understand what they are saying. 1 2 3 4 5
APPENDIX C: Mishel’s Uncertainty in Illness Scale – Community Form
Please read each statement. Take your time about what each statement says. Then 






























1. 내 상태가 얼마나 나쁜지 모르겠다. 1 2 3 4 5
1. 나는 궁금한 것이 많다. 1 2 3 4 5
2. 내가 더 좋아질지, 나빠질지 확신이 없다. 1 2 3 4 5
3. 앞으로의 치료계획이 얼마나 나쁠지 알 수 없다. 1 2 3 4 5
4. 나는 의료진이 내 병에 대해 설명한 것을 이해하지 못한다. 1 2 3 4 5
5. 나는 내가 왜 이 치료를 받는지 알고 있다. 1 2 3 4 5
6. 내 증상들은 계속해서 바뀐다. 1 2 3 4 5
7. 나는 설명들은 내용을 모두 이해한다. 1 2 3 4 5
8. 의사들이 내게 설명한 것들은 혼란스럽다. 1 2 3 4 5
9. 내가 받는 치료는 이해하기가 너무 어렵다. 1 2 3 4 5
10. 내가 받는 치료나 약물이 나에게 효과가 있을지 없을지 모르겠
다. 1 2 3 4 5
11. 내 상태가 계속 변하므로 앞날을 계획할 수 없다. 1 2 3 4 5
12. 내 병의 경과가 계속 바뀌므로 좋은 날도 있고 안 좋은 날도 
있다. 1 2 3 4 5
13. 내 문제에 대해 의료진들이 서로 다른 이야기를 한다. 1 2 3 4 5
14. 앞으로 내게 무슨 일이 생길지 확실치 않다. 1 2 3 4 5
15. 검사에 따라 검사 결과가 다르다. 1 2 3 4 5
16. 내가 받는 치료가 효과가 있을지 모르겠다. 1 2 3 4 5
17. 치료 때문에 내가 할 수 있는 일들이 계속 달라진다. 1 2 3 4 5
18. 의료진들은 내 병에 대해 더 이상 나쁜 것을 찾지 못할 것이
다. 1 2 3 4 5
19. 내가 받는 치료는 전에 다른 사람들에게 효과가 있었던 치료이
다. 1 2 3 4 5
20. 의료진은 나에게 정확한 진단명을 말해주지 않았다. 1 2 3 4 5
21. 나는 내 병이 어느 정도 심각한지 안다. 1 2 3 4 5
22. 나는 의사와 간호사들이 쓰는 용어를 이해할 수 있다. 1 2 3 4 5
불확실성 척도 (Mishel uncertainty in illness scale – Community form)
다음은 귀하께서 질병이나 치료 진행 과정에 대해 어떻게 생각하시는지에 대해 알고자 


















1. There is a special person who is around when I am 
  in need. 1 2 3 4 5
2. There is a special person with whom I can share my 
  joys and sorrows. 1 2 3 4 5
3. My family really tries to help me. 1 2 3 4 5
4. I get the emotional help and support I need from 
  my family. 1 2 3 4 5
5. I have a special person who is a real source of 
  comfort to me. 1 2 3 4 5
6. My friends really try to help me. 1 2 3 4 5
7. I can count on my friends when things go wrong. 1 2 3 4 5
8. I can talk about my problems with my family 1 2 3 4 5
9. I have friends with whom I can share my joys and
  sorrows. 1 2 3 4 5
10. There is a special person in my life who cares
   about my feelings. 1 2 3 4 5
11. My family is willing to help me make decisions. 1 2 3 4 5
12. I can talk about my problems with my friends. 1 2 3 4 5
APPENDIX D: Multidimensional Scale of Perceived Social Support
Please read each statement. Take your time about what each statement says. Then 






























1. 내 주위에는 내가 어려울 때 나를 도와 줄 특별한 사람  
  (의사, 간호사)이 있다. 1 2 3 4 5
2. 나에게는 나의 슬픔과 기쁨을 함께 나눌 특별한 사람   
  (의사, 간호사)이 있다. 1 2 3 4 5
3. 나의 가족들은 나에게 도움을 주고자 진정으로 노력한다. 1 2 3 4 5
4. 나는 내가 필요로 하는 정서적 도움과 지지를 
  가족들로부터 얻는다. 1 2 3 4 5
5. 나에게는 나를 진정으로 위로해 줄 특별한 사람
  (의사, 간호사)이 있다. 1 2 3 4 5
6. 나의 친구들은 나에게 도움을 주고자 진정으로 노력한다. 1 2 3 4 5
7. 어떤 일들이 잘못되었을 때 나는 나의 친구에게 의지할 수
  있다. 1 2 3 4 5
8. 나는 나의 문제들에 대해 가족들과 이야기를 나눌 수 있다. 1 2 3 4 5
9. 나는 나의 슬픔과 기쁨을 함께 나눌 친구들이 있다. 1 2 3 4 5
10. 내 인생에는 나의 감정을 보살펴 주는 특별한 사람
   (의사, 간호사)이 있다. 1 2 3 4 5
11. 나의 가족들은 내가 어떤 일을 결정할 때 기꺼이 도움을 
   주려고 한다 1 2 3 4 5
12. 나는 나의 문제에 대하여 친구들과 이야기를 나눌 수 
    있다. 1 2 3 4 5
사회적 지지 척도 (Multidimensional Scale of Perceived Social Support)
다음의 문장들은 귀하가 느끼시는 사회적 지지에 대한 설문입니다.



















1. Repeated, disturbing memories, thoughts, or images 
  of a stressful experience from the past? 1 2 3 4 5
2. Repeated, disturbing dreams of a stressful 
  experience from the past? 1 2 3 4 5
3. Suddenly acting or feeling as if a stressful 
  experience were happening again (as if you were 
  reliving it)?
1 2 3 4 5
4. Feeling very upset when something reminded you 
  of a stressful experience from the past? 1 2 3 4 5
5. Having physical reactions (e.g. heart pounding, 
  trouble breathing, or sweating) when something   
reminded you of a stressful experience from the past?
1 2 3 4 5
6. Avoid thinking about or talking about a stressful 
  experience from the past or avoid having feelings 
  related to it?
1 2 3 4 5
7. Avoid activities or situations because they remind 
  you of a stressful experience from the past? 1 2 3 4 5
8. Trouble remembering important parts of a stressful 
  experience from the past? 1 2 3 4 5
9. Loss of interest in things that you used to enjoy? 1 2 3 4 5
10. Feeling distant or cut off from other people? 1 2 3 4 5
11. Feeling emotionally numb or being unable to have 
   loving feelings for those close to   you? 1 2 3 4 5
12. Feeling as if your future will somehow be cut 
   short?
1 2 3 4 5
13. Trouble falling or staying asleep? 1 2 3 4 5
14. Feeling irritable or having angry outbursts? 1 2 3 4 5
15. Having difficulty concentrating? 1 2 3 4 5
16. Being “super alert” or watchful on guard? 1 2 3 4 5
17. Feeling jumpy or easily startled? 1 2 3 4 5
APPENDIX E: PTSD Checklist – Civilian version
Instructions: Below is a list of problems that people sometimes have in response to 
a very stressful experience. Please read each problem carefully and then circle one 
































1. 과거의 스트레스적인 경험으로 인해 반복적으로 방해되는 
  기억과 생각 또는 이미지가 떠오르나요? 1 2 3 4 5
2. 과거의 스트레스적인 경험으로 인해 반복적으로 수면을 
  방해합니까? 1 2 3 4 5
3. 스트레스적인 경험이 다시 발생하거나 일어날 것 같은 느
  낌을 느낍니까? 1 2 3 4 5
4. 무언가로 인해 스트레스적인 경험을 상기시킨다면 매우 불
  편감을 느낍니까? 1 2 3 4 5
5. 무언가로 인해 스트레스적인 경험을 상기시켰을 때 신체적 
  반응(두근거림, 호흡곤란, 식은땀)을 경험한 적이 있습니까? 1 2 3 4 5
6. 스트레스적인 경험과 그와 관련된 감정에 대해 생각하거나 
  대화를 피하십니까? 1 2 3 4 5
7. 어떤 활동이나 상황이 스트레스적인 경험을 상기시킨다면 
  피하시겠습니까? 1 2 3 4 5
8. 스트레스적인 경험의 중요한 부분을 기억하는데 어려움이 
  있습니까? 1 2 3 4 5
9. 당신이 평소 즐기는 것들에 대해 흥미를 잃으셨나요? 1 2 3 4 5
10. 타인과 연락을 하지 않거나 거리를 둔다고 느끼십니까? 1 2 3 4 5
11. 당신과 가까운 사람에 대해 사랑을 느끼기 어렵거나 감정
   적으로 무감각함을 느낍니까? 1 2 3 4 5
12. 왠지 당신의 미래가 갑작스럽게 끝날 것 같습니까? 1 2 3 4 5
13. 잠을 자거나 잠이 들기까지 어려움을 느끼십니까? 1 2 3 4 5
14. 짜증을 내거나 갑작스럽게 화가 나십니까? 1 2 3 4 5
15. 무언가에 집중하는데 어려움을 느낍니까? 1 2 3 4 5
16. 주변을 경계하거나 예민함을 느낍니까? 1 2 3 4 5
17. 쉽게 놀라거나 조마조마함을 느낍니까? 1 2 3 4 5
PCL-C (Korean Version)
다음의 문장들은 귀하가 느끼시는 외상 후 스트레스에 대한 설문입니다.




















1. My situation has opened new possibilities for me 1 2 3 4 5
2. I greet each day with more joy. 1 2 3 4 5
3. I fear the unexpected more now. 1 2 3 4 5
4. My dreams are clearer to me now. 1 2 3 4 5
5. I focus more now on what is important in life. 1 2 3 4 5
6. My life has new meaning. 1 2 3 4 5
7. I am more able to “go with the flow.” 1 2 3 4 5
8. I now view change in my life as more of a threat. 1 2 3 4 5
9. My priorities have now changed. 1 2 3 4 5
10. I have structured a new way of living. 1 2 3 4 5
11. I have a new perspective on life 1 2 3 4 5
12. I now greet surprises with more joy. 1 2 3 4 5
13. I see new opportunities in my everyday routine. 1 2 3 4 5
14. I have a new sense of what is important. 1 2 3 4 5
15. My views about how to do things have broadened. 1 2 3 4 5
16. I now consider many different alternatives. 1 2 3 4 5
17. I am more comfortable with taking changes as they come. 1 2 3 4 5
18. I am more aware of what is important to me. 1 2 3 4 5
19. My relationships with others have new meaning. 1 2 3 4 5
20. I am now more likely to do things because I want to do 
them.
1 2 3 4 5
21. Some activities that I used to do don’t seem so important 
now.
1 2 3 4 5
22. My future goals are now more flexible. 1 2 3 4 5
23. I am now more afraid of how I will end up. 1 2 3 4 5
24. When thinking about my future, I now try to be more 
flexible.
1 2 3 4 5
25. It is more important to me now to try to make the best of 
each situation.
1 2 3 4 5
26. I now try to challenge myself more. 1 2 3 4 5
27. Things I have taken for granted before now take on a new 
meaning.
1 2 3 4 5
28. The uncertainty of my child’s illness is now the greatest 
worry I have to deal with.
1 2 3 4 5
29. I don’t plan for the future now as much as I did before my 1 2 3 4 5
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illness.
30. I create new rules and expectations for my life. 1 2 3 4 5
31. I am now learning about letting go of control. 1 2 3 4 5
32. I now respect the future more as an unknown. 1 2 3 4 5
33. I don’t worry as much about what could happen tomorrow. 1 2 3 4 5
34. Now I don’t get as upset at the little things. 1 2 3 4 5
35. I don’t put things off until later as much as I did before. 1 2 3 4 5
36. Now I have learned to adapt to the unexpected. 1 2 3 4 5
37. I now accept change and unpredictability more as a positive 
way of life.
1 2 3 4 5
38. My values have changed. 1 2 3 4 5






























1.  지금 상황은 나에게 새로운 가능성으로 열려있다. 1 2 3 4 5
2.  나는 매일 하루를 즐겁게 맞이한다. 1 2 3 4 5
3.  나는 지금보다 예측할 수 없는 미래가 두렵다 1 2 3 4 5
4.  현재 내 꿈이 더욱 확실해졌다. 1 2 3 4 5
5.  나는 현재 내 인생에 중요한 것들을 집중할 수 있다. 1 2 3 4 5
6.  나는 내 인생의 새로운 의미를 가진다. 1 2 3 4 5
7.  나는 좀 더 대세에 순응할 수 있다. 1 2 3 4 5
8.  나는 내 인생의 위협에 대해 관점이 변했다. 1 2 3 4 5
9.  나의 우선순위가 현재 바꿨다. 1 2 3 4 5
10. 나는 새로운 삶의 방식을 건설했다. 1 2 3 4 5
11. 나는 내 인생에 대해 새로운 관점을 가졌다. 1 2 3 4 5
12. 나는 현재 즐거움으로 예상치 못한 상황을 맞이할 수 있
다. 1 2 3 4 5
13. 나는 매일 일상적인 하루를 새로운 기회로 본다. 1 2 3 4 5
14. 나는 무엇이 중요한지를 알 수 있는 새로운 감각을 가졌
다. 1 2 3 4 5
15. 사물에 대한 나의 관점은 넓어졌다. 1 2 3 4 5
16 나는 현재 다양한 대안 책들을 고려한다. 1 2 3 4 5
17. 나는 앞으로 올 수 있는 변화를 좀 더 편안하게 받아들
일 수 있다. 1 2 3 4 5
18. 나는 나에게 중요한 것을 더 잘 안다. 1 2 3 4 5
19. 타인과의 관계에서 좀 더 새로운 의미를 가진다. 1 2 3 4 5
20. 현재 나는 내가 원하는 것들이기 때문에 할 수 있을 것 
같다. 1 2 3 4 5
21. 나는 과거에 했던 몇몇 활동들이 현재는 중요하지 않다
고 본다. 1 2 3 4 5
22. 나의 미래 목표는 좀 더 유연성 있다. 1 2 3 4 5
23. 나는 현재 내가 어떻게 끝내게 될지 두렵다. 1 2 3 4 5
24. 내 미래에 대해 생각할 때 현재 나는 좀 더 유연성 있도
록 노력한다. 1 2 3 4 5
25. 나는 현재 각각 최선의 상황을 만들 수 있도록 노력하는 
것이 좀 더 중요하다. 1 2 3 4 5
26. 나는 내 스스로 좀더 도전적으로 노력하고자 한다. 1 2 3 4 5
27. 예전에 나에게 주어진 것들을 현재 새로운 의미로 받아
들인다. 1 2 3 4 5
28. 내 어린 시절 질병에 대한 불확실성은 지금 내가 다뤄야 
할 가장 큰 고민이다. 1 2 3 4 5
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29. 나는 질환을 얻기 전 만큼 미래에 대한 계획이 없다. 1 2 3 4 5
30. 나는 내 인생을 위한 기대와 새로운 규칙들을 만들었다. 1 2 3 4 5
31. 현재 나는 통제를 내버려두는 것에 대해 배운다. 1 2 3 4 5
32. 나는 현재 앞으로 알지 못하는 미래를 존중한다. 1 2 3 4 5
33. 나는 내일 일어날 수 있는 것들에 대해 가능한 걱정하지 
않는다. 1 2 3 4 5
34. 나는 현재 작은 일에 대해 흥분하지 않는다. 1 2 3 4 5
35. 나는 예전만큼 뒤로 미루지 않는다. 1 2 3 4 5
36. 현재 나는 기대하지 못한 것에 대해 적응하는 것을 배웠
다. 1 2 3 4 5
37. 현재 나는 변화와 예측할 수 없는 것들을 좀더 긍정적인 
삶의 방향으로 받아들인다. 1 2 3 4 5
38. 나의 가치는 변했다. 1 2 3 4 5
39. 나는 예전처럼 삶을 예측할 수 있길 기대하지 않는다. 1 2 3 4 5
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APPENDIX H: PERMISSION TO USE THE INSTRUMENTS
The following are the copies of the e-mail to prove the permission to 






본 연 는 혈액암  진단 고 치료  환  확실 , 
사회 지지, 상 후 스트 스 상과 심리   악하고, 
확실 과 사회 지지가 상 후 스트 스 상과 심리  에 
미치는 향  규 하여, 혈액암 환 들  상  화시킬 수 는 
재  개 하는  어 료  공하고  하는 횡단 , 술  
상 계 연 다.
연 상  울특별시 재  S 합 병원에  혈병, 림프 , 
다  골수  등  혈액암  진단 고, 극  치료 혹  래에  
후 리  고 는 환  166  상  하 다. 2014  6월 
29  9월 1 지 연 에 참여하  동 한 혈액암 환 에게 
문지  료  수집하 다.
연 도 는 확실  Mishel’s Uncertainty in Illness Scale – 
Community form (MUIS-C) , 사회  지지는 Multidimensional Scale 
Perceived Social Support (MSPSS) , 상 후 스트 스 상   PTSD 
Checklist – Civilian version (PCL-C), 심리   Growth Through 
Uncertainty Scale (GTUS)  사 하 다.
수집한 료는 SPSS/WIN 21.0프 그램  하여 빈도, , 
평균, 편차, t-test, one-way ANOVA, Scheffe 사후 검 , Pearson 
correlation, 다 회귀   하 고 다 과 같  결과  
얻었다.
1) 확실  평균 61.06(±13.64) , 사회  지지는 평균 42.79(±8.10) , 
상  후 스트 스 상  평균 44.02(±13.45) 고 심리   
132.10(±20.39)  나타났다.
2) 연 , 도, 진단 간, 식과 재 여 , 재 여  원여 에 
라 확실  통계  한 차 가 었다.
3) 도, 혈액암 , 진단 간에 라 사회 지지가 통계  
한 차 가 었다.
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4) 연 에 라 상 후 스트 스 상  통계  한 차 가 
었다.
5) 확실 , 사회 지지, 상 후 스트 스 상과 심리   
통계  한 상 계가 었다 (p<.001).
6) 확실 , 사회 지지가 상 후 스트 스 상에 향  미치는 
 규 었다 (R2=.312, p<.000).
7) 사회 지지, 식과 재 여 , 신과치료여  경 상태가 심리  
에 향  미치는  규 었다 (R2=.231, p<.000).
본 연 는 혈액암 환  확실 , 사회 지지, 상 후 
스트 스 상과 심리   도  향  미치는  규 하여 
혈액암 환  상 후 스트 스  화할 수 는 재  개 에 
 료  공하 다는  가 다.  탕  상 후 
스트 스  심리  에 향  미치는 변수  확실  경감하고 
사회  지지  가시킬 수 는  간호 재 프 그램  개 하여 
그 효과  검 하는 연 가 필 하다.
주 어: 확실 , 사회 지지, 상 후 스트 스 상, 심리  , 
혈액암
학 : 2012-20423
